<--- Back to Details
First PageDocument Content
Biotechnology / EuropaBio / European Federation of Pharmaceutical Industries and Associations / Rare disease / Pharmaceutical industry / European Organization for Rare Diseases / European Medicines Agency / Pharmaceutical sciences / Pharmacology / Science
Date: 2015-05-08 08:51:14
Biotechnology
EuropaBio
European Federation of Pharmaceutical Industries and Associations
Rare disease
Pharmaceutical industry
European Organization for Rare Diseases
European Medicines Agency
Pharmaceutical sciences
Pharmacology
Science

The Honourable Members of the European Parliament Ms Françoise Grossetête and Mr Philippe de Backer With the support of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the European Ass

Add to Reading List

Source URL: www.efpia.eu

Download Document from Source Website

File Size: 232,65 KB

Share Document on Facebook

Similar Documents

Paris, 25 MayPress releaseThe Prix Galien was awarded to LFB in the

Paris, 25 MayPress releaseThe Prix Galien was awarded to LFB in the "Medicine for the Treatment of Rare Diseases" category The 2011 Prix Galien was awarded on 25 May, in the presence of Ms Valérie Pécresse, Min

DocID: 1aMJE - View Document

REPORT ON RARE DISEASE RESEARCH, ITS DETERMINANTS IN EUROPE AND THE WAY FORWARD  May 2011

REPORT ON RARE DISEASE RESEARCH, ITS DETERMINANTS IN EUROPE AND THE WAY FORWARD May 2011

DocID: 1amr3 - View Document

EU XXV.GP Eingelangt amEUROPEAN COMMISSION

EU XXV.GP Eingelangt amEUROPEAN COMMISSION

DocID: 1agjJ - View Document

European Strategy on Rare Diseases is Adopted by Health Ministers of the EU A European strategy that calls upon Member States to implement national plans for rare diseases, before the end of 2013, was adopted by the Coun

European Strategy on Rare Diseases is Adopted by Health Ministers of the EU A European strategy that calls upon Member States to implement national plans for rare diseases, before the end of 2013, was adopted by the Coun

DocID: 1a5Lc - View Document

Now is the Time:  A Strategy for Rare Diseases is a Strategy for all Canadians EXECUTIVE SUMMARY: CANADA’S RARE DISEASE STRATEGY

Now is the Time: A Strategy for Rare Diseases is a Strategy for all Canadians EXECUTIVE SUMMARY: CANADA’S RARE DISEASE STRATEGY

DocID: 19PNo - View Document